New cancer pill tested in patients who ran out of options
Disease control
Completed
This first-in-human study tested a new oral medication called MRX-2843 in adults with advanced solid tumors that had returned or stopped responding to standard treatments. The main goals were to find the highest safe dose and understand how the drug moves through the body. Resear…
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC